Share

Updates matching "Access to Biomarker Testing"

January 3, 2023
Ohio

As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

January 3, 2023
Kentucky

Kentucky Can and Must Do Better When it Comes to Reducing the Cancer Burden

December 18, 2022
Ohio

As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

December 12, 2022
New York

ALBANY , NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany. WHEN : Santa Clause and

December 6, 2022
New York

The following was originally published in the Empire Report on December 6, 2022. With over 118,000 New Yorkers forced to hear the dreaded three words “you have cancer” every year, it’s easy to forget the incredible strides in early detection and treatment we’ve made in the last 20

June 21, 2022
California

The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.

May 19, 2022
Rhode Island

Today, the Rhode Island Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.

May 6, 2022
Texas

WICHITA FALLS, TX – May 6, 2022 – Family and friends recall former Wichita Falls resident Jackie Bush as the definition of bravery, strength and a force to be reckoned with. She undoubtedly left her mark in Texas, and on the hearts of fellow volunteers and legislatures as a lead

April 21, 2022
California

The California Senate Health Committee voted to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.